Michael J Rock
Overview
Explore the profile of Michael J Rock including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
1190
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang L, Lai H, Furuya K, Antos N, Asfour F, Boyne K, et al.
Pediatr Pulmonol
. 2025 Mar;
60(3):e71042.
PMID: 40071665
Background: Genetic modifiers have been identified that increase the risks of lung disease and other complications, such as diabetes in people with cystic fibrosis (CF). Variants in the hemochromatosis gene...
2.
Hayden H, Nelson M, Ross S, Verster A, Bouzek D, Eng A, et al.
Pediatr Pulmonol
. 2025 Mar;
60(3):e71024.
PMID: 40042126
Background: Systemic antibiotics can impact all microbes inhabiting patients, regardless of the intended target organism(s). We studied the simultaneous effects on respiratory and fecal microbiomes of β-lactam antibiotics administered for...
3.
Liu C, Bach T, Farrell P, Pavelec D, Antos N, Rock M, et al.
J Pediatr Gastroenterol Nutr
. 2024 Oct;
79(6):1124-1133.
PMID: 39465618
Objective: Acid blocker therapy (ABT) has become common in cystic fibrosis (CF), despite insufficient evidence for benefits and studies showing potentially negative effects. We examined associations between ABT usage and...
4.
Walkup L, Roach D, Plummer J, Willmering M, Zanette B, Santyr G, et al.
J Magn Reson Imaging
. 2024 Sep;
61(4):1664-1674.
PMID: 39257323
Background: MRI with xenon-129 gas (Xe MRI) can assess airflow obstruction and heterogeneity in lung diseases. Specifically, Xe MRI may represent a sensitive modality for future therapeutic trials of cystic...
5.
Rock M, Baker M, Farrell P
Pediatr Pulmonol
. 2023 Jul;
58(11):3342-3345.
PMID: 37503874
No abstract available.
6.
Rock M, Baker M, Antos N, Farrell P
Pediatr Pulmonol
. 2022 Nov;
58(3):778-787.
PMID: 36416003
Background: Newborn screening for cystic fibrosis (CF) has been underway universally in the United States for more than a decade, as well in most European countries, and algorithms have been...
7.
Huang L, Lai H, Antos N, Rock M, Asfour F, Howenstine M, et al.
Pediatr Pulmonol
. 2022 Jun;
57(10):2363-2373.
PMID: 35712759
Background: Because of the heterogeneity in cystic fibrosis (CF) lung disease among young children, a clinical method to identify early-onset lung disease is needed. Objective: To develop a CF early-onset...
8.
Zhang X, Hothi J, Zhang Y, Ren A, Rock M, Srinivasan S, et al.
Life (Basel)
. 2021 Feb;
11(2).
PMID: 33567498
(1) Background: many rare (CFTR) mutations remain poorly characterized with regard to functional consequences of the mutation. We present the clinical features of two pediatric cystic fibrosis (CF) subjects who...
9.
Barreda C, Farrell P, Laxova A, Eickhoff J, Braun A, Coller R, et al.
J Cyst Fibros
. 2020 Jun;
20(3):492-498.
PMID: 32546430
Background: The Wisconsin Cystic Fibrosis Neonatal Screening Project was a randomized clinical trial (RCT) revealing that children receiving an early diagnosis of CF via newborn screening (NBS) had improved nutritional...
10.